Sodium Stearyl Fumarate & SODIUM STEARYL FUMARATE Excipient Excipient Use in Tablet Orally Disintegrating Delayed Release Dosage Forms

Sodium Stearyl Fumarate

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

10 Listed Products, 1 SPI Pharma, 1 Prachin Chemical, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Alcedo Pharmachem, 1 Gangwal Healthcare, 1 Pharmatrans-Sanaq, 1 Minakem, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Jai Radhe Sales

REGULATORY FILINGS

16 Suppliers, 12 USDMF, 2 CEP/COS, 2 NDC API, 2 Listed Suppliers

SOLUTIONS BY APPLICATIONS

6 Lubricants & Glidants, 2 Chewable & Orodispersible Aids, 2 Disintegrants & Superdisintegrants, 1 Fillers, Diluents & Binders, 1 Thickeners and Stabilizers, 1 Coating Systems & Additives

ANALYTICAL SOLUTION(s)

1 USP Standards, 1 Other Ref. Standards

FINISHED FORMULATIONS

156 ORAL, 73 TABLET, 29 TABLET, EXTENDED RELEASE, 23 CAPSULE, 16 TABLET, ORALLY DISINTEGRATING, 11 TABLET, DELAYED RELEASE, 3 SUBLINGUAL, 2 CAPSULE, EXTENDED RELEASE, 2 INTRAVENOUS, 2 TABLET, FOR SUSPENSION, 1 CAPSULE, DELAYED RELEASE, 1 FOR SUSPENSION, 1 POWDER, 1 SOLUTION, 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE